Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response von Pierga, J.-Y, Mouret, E, Laurence, V, Diéras, V, Savigioni, A, Beuzeboc, P, Dorval, T, Palangié, T, Jouve, M, Pouillart, P

Volltext

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer von Pierga, J-Y, Mouret, E, Diéras, V, Laurence, V, Beuzeboc, P, Dorval, T, Palangié, T, Jouve, M, Vincent-Salomon, A, Scholl, S, Extra, J-M, Asselain, B, Pouillart, P

Volltext

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6 von Scholl, S.M., Fourquet, A., Asselain, B., Pierga, J.Y., Vilcoq, J.R., Durand, J.C., Dorval, T., Palangié, T., Jouve, M., Beuzeboc, P., Garcio-Giralt, E., Salmon, R.J., de la Rochefordière, A., Campana, F., Pouillart, P.

Volltext

BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic von STOPPA-LYONNET, D, LAURENT-PUIG, P, BONAÏTI-PELLIE, C, THOMAS, G, ESSIOUX, L, PAGES, S, ITHIER, G, LIGOT, L, FOURQUET, A, SALMON, R. J, CLOUGH, K. B, POUILLART, P

Volltext

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival von Scholl, S.M., Pierga, J.Y., Asselain, B., Beuzeboc, P., Dorval, T., Garcia-Giralt, E., Jouve, M., Palangié, T., Remvikos, Y., Durand, J.C., Fourquet, A., Pouillart, P.

Volltext

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first‐line doxorubicin‐containing chemotherapy von Pierga, Jean‐Yves, Asselain, Bernard, Jouve, Michel, Diéras, Véronique, Carton, Mathieu, Laurence, Valérie, Girre, Véronique, Beuzeboc, Philippe, Palangié, Thao, Dorval, Thierry, Pouillart, Pierre

Volltext

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer : toxicity and response (PEGASE 02 tri... von VIENS, P, PALANGIE, T, COSTA, B, DELVA, R, CURE, H, ROUSSEAU, F, GUILOT, A, MOUSSEAU, M, FERRERO, J. M, BARDOU, V. J, JACQUEMIER, J, POUILLART, P, JANVIER, M, FABBRO, M, ROCHE, H, DELOZIER, T, LABAT, J. P, LINASSIER, C, AUDHUY, B, FEUILHADE, F

Volltext

Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patients von Pierga, J. Y., Robain, M., Jouve, M., Asselain, B., Diéras, V., Beuzeboc, P., Palangié, T., Dorval, T., Extra, J.-M., Scholl, S., Pouillart, P.

Volltext

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy von Vincent-Salomon, A., Carton, M., Freneaux, P., Palangie, T., Beuzeboc, P., Mouret, E., de Crémoux, P., Coué, O., Zafrani, B., Nicolas, A., Clough, K., Fourquet, A., Pouillart, P., Sastre-Garau, X.

Volltext

High-Dose Sequential Chemotherapy With Recombinant Granulocyte Colony-Stimulating Factor and Repeated Stem-Cell Support for Inflammatory Breast Cancer Patients: Does Impact on Qual... von MACQUART-MOULIN, G, VIENS, P, PALANGIE, T, BOUSCARY, M.-L, DELOZIER, T, ROCHE, H, JANVIER, M, FABBRO, M, MOATTI, J.-P

Volltext

Prognostic factors in inflammatory breast cancer and therapeutic implications von Palangie, T., Mosseri, V., Mihura, J., Campana, F., Beuzeboc, P., Dorval, T., Garcia-Giralt, E., Jouve, M., Scholl, S., Asselain, B., Pouillart, P.

Volltext

Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancer von Robain, M., Pierga, J.Y., Jouve, M., Asselain, B., Diéras, V., Beuzeboc, P., Palangié, T., Dorval, T., Extra, J.-M., Scholl, S., Pouillart, P.

Volltext

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer von SCHOLL, S. M, BASCOU, C. H, MOSSERI, V, OLIVARES, R, MAGDELENAT, H, DORVAL, T, PALANGIE, T, VALIDIRE, P, POUILLART, P, STANLEY, E. R

Volltext

Neoadjuvant chemotherapy in young breast cancer patients: correlation between response and relapse? von Braud, A.C, Asselain, B, Scholl, S, De La Rochefordière, A, Palangie, T, Dieras, V, Pierga, J.Y, Dorval, T, Jouve, M, Beuzeboc, P, Pouillart, P

Volltext

Neoadjuvant chemotherapy in operable breast cancer von Scholl, S.M., Asselain, B., Palangie, T., Dorval, T., Jouve, M., Garcia Giralt, E., Vilcoq, J., Durand, J.C., Pouillart, P.

Volltext

Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90... von Pierga, J-Y, Jouve, M, Asselain, B, Livartowski, A, Beuzeboc, P, Diéras, V, Scholl, S, Dorval, T, Palangié, T, Garcia-Giralt, E, Pouillart, P

Volltext

Phase II Trial of Doxorubicin, 5-Fluorouracil, Etoposide, and Cisplatin in Advanced or Recurrent Endometrial Carcinoma von Pierga, J-Y., Diéras, V., Beuzeboc, P., Dorval, T., Palangié, T., Jouve, M., Scholl, S.M., Garcia-Giralt, E., Pouillart, P.

Volltext

Five years update of sequential high dose doxorubicin, cyclophosphamide and docetaxel in inflammatory breast cancer; PEGAGE05 trial on behalf of FNLCC von Palangie, T., Pouillart, P., Roche, H., Viens, P., Linassier, C.

Volltext

Treatment of Advanced or Recurrent Endometrial Carcinoma with Combination of Etoposide, Cisplatin, and 5-Fluorouracil: A Phase II Study von Pierga, J-Y., Dieras, V., Paraiso, D., Dorval, T., Palangie, T., Beuzeboc, P., Jouve, M., Scholl, S.M., Garcia-Giralt, E., Pouillart, P.

Volltext

Resection of pulmonary metastases in osteosarcoma. A retrospective analysis of 44 patients von Belli, Laura, Scholl, Susy, Livartowski, Alain, Ashby, Michael, Palangie, Thao, Levasseur, Philippe, Pouillart, Pierre

Volltext